Back
Nektar Therapeutics Quote, Financials, Valuation and Earnings
Sell
42
NKTR
Nektar Therapeutics
Last Price:
1.76
Seasonality Move:
-3.09%
7 Day Trial
ALL ACCESS PASS
$
7
Nektar Therapeutics Price Quote
$1.76
+0.01 (+-2.22%)
(Updated: May 18, 2024 at 5:15 AM ET)
Nektar Therapeutics Key Stats
Sell
42
Nektar Therapeutics (NKTR)
is a Sell
Day range:
$1.72 - $1.81
52-week range:
$0.41 - $1.93
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
3.73
P/B ratio:
2.54%
Volume:
1.1M
Avg. volume:
2.5M
1-year change:
150.71%
Market cap:
$322.3M
Revenue:
$90.1M
EPS:
$-0.92
How Much Does Nektar Therapeutics Make?
-
How Much Are Nektar Therapeutics's Sales Annually?
NKTR Revenues are $90.1M -
How Much Profit Does Nektar Therapeutics's Make A Year?
NKTR net income is -$276.1M
Is Nektar Therapeutics Growing As A Company?
-
What Is Nektar Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0% -
What Is Nektar Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Nektar Therapeutics Stock Price Performance
-
Did Nektar Therapeutics Stock Go Up Last Month?
Nektar Therapeutics share price went up by 30% last month -
Did NKTR's Share Price Rise Over The Last Year?
NKTR share price rose by 150.71% over the past 1 year
What Is Nektar Therapeutics 52-Week High & Low?
-
What Is Nektar Therapeutics’s 52-Week High Share Price?
Nektar Therapeutics has traded as high as $1.93 over the past 52 weeks -
What Is Nektar Therapeutics’s 52-Week Low Share Price?
Nektar Therapeutics has traded as low as $0.41 over the past 52 weeks
Nektar Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Nektar Therapeutics?
-
How Much Debt Does Nektar Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Nektar Therapeutics Have?
Cash and short term investments quarterly total is $289.2M -
What Is Nektar Therapeutics’s Book Value Per Share?
Book value per share is 0.69
Is Nektar Therapeutics Cash Flow Positive?
-
What Is NKTR Cash Flow From Operations?
Cash flow from operations (TTM) is -$188.6M -
What Is Nektar Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $42M -
What Is Nektar Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $118.2M
Nektar Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
NKTR return on invested capital is -102.85% -
What Is Nektar Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -38.35% -
What Is NKTR Return On Equity?
ROE is a measure of profitability and is -102.85%
Nektar Therapeutics Earnings Date & Stock Price
-
What Is Nektar Therapeutics's Stock Price Today?
A single share of NKTR can be purchased today for 1.76 -
What Is Nektar Therapeutics’s Stock Symbol?
Nektar Therapeutics trades on the nasdaq under the ticker symbol: NKTR -
When Is Nektar Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Nektar Therapeutics is scheduled on August 8, 2024 -
When Is NKTR's next ex-dividend date?
Nektar Therapeutics's next ex-dividend date is May 18, 2024 -
How To Buy Nektar Therapeutics Stock?
You can buy Nektar Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Nektar Therapeutics Competitors
-
Who Are Nektar Therapeutics's Competitors?
Below is a list of companies who compete with Nektar Therapeutics or are related in some way:
Nektar Therapeutics Dividend Yield
Data Unavailable
Nektar Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 10.24% |
| Revenue: | 0.21% | 41.05% |
Analyst Recommendations
| Buy Recommendations: | 0 |
|---|---|
| Hold Recommendations: | 3 |
| Sell Recommendations: | 0 |
| Price Target: | 1.60 |
| Downside from Last Price: | -8.83% |